Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,646 public trials 848 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Multicenter Phase II Study to Evaluate the Clinical Activity and the Safety Profile of Everolimus in Marginal Zone B-cell Lymphomas (MZL)

NCT01164267

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • General Hospital AKH Vienna, Austria
  • Policlinico S. Orsola Malpighi Bologna, Italy
  • Humanitas Milan, Italy
  • San Raffaele Hospital Milan, Italy
View Trial Details
Completed

Early Treatment Stratification Based on PET Scan Response to Chemotherapy in Patients With Diffuse Large B-cell Lymphoma

NCT01361191

Conditions
Diffuse Large B-cell Lymphoma, Follicular Grade 3B Lymphoma, Hemic and Lymphatic Diseases, +10 more
Locations
  • ICO- Hospital Duran i Reynals L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital Universitario Marques de Valdecilla Santander, Cantabria, Spain
  • Hospital de Jerez Jerez de la Frontera, Cádiz, Spain
  • Hospital Clínico Univ. de Santiago Santiago de Compostela, Galicia, Spain
View all 19 locations
View Trial Details
Completed

Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin's Lymphoma Patients

NCT00949741

Conditions
Burkitt Lymphoma, Burkitt's Lymphoma, DNA Virus Infections, +22 more
Locations
  • ASO SS Antonio e Biagio e Cesare Arrigo Alessandria, AL, Italy
  • PO Centro Binaghi Divisione di Ematologia CTMO Cagliari, CA, Italy
  • Az. Ospedaliero Universitaria Careggi Florence, FI, Italy
  • Ospedale Vito Fazzi Divisione di Ematologia Lecce, LE, Italy
View Trial Details
Completed

Bortezomib and Fludarabine With or Without Rituximab in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

NCT00068315

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +41 more
Locations
  • Mercy Medical Center Canton, Ohio, United States
  • Case Western Reserve University Cleveland, Ohio, United States
  • Seidman Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Southwest General Health Center Ireland Cancer Center Middleburg Heights, Ohio, United States
View Trial Details
Completed

Safety and Efficacy of IDEC-114 in Combination With Rituxan in the Treatment of Non-Hodgkin's Lymphoma

NCT00048555

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Research site Birmingham, Alabama, United States
  • Research site Tucson, Arizona, United States
  • Research site Los Angeles, California, United States
  • Research site Newport Beach, California, United States
View all 22 locations
View Trial Details
Completed

Malaria Treatment With Injectable ArteSunate

NCT01828333

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +14 more
Locations
  • Centre de Santé CECO Kimpese, Bas-Congo Province, Democratic Republic of the Congo
  • Centre de Santé la Famille Kimpese, Bas-Congo Province, Democratic Republic of the Congo
  • Hôpital Général de Référence IME Kimpese, Bas-Congo Province, Democratic Republic of the Congo
  • Centre de Santé Ngeba Kisantu, Bas-Congo Province, Democratic Republic of the Congo
View Trial Details

Related conditions